Task: Answer the MCQ question.
Question: Which compound exhibits a 9.730% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a. Cc1ccc(N2C(=O)CN(Cc3ccccc3)C2=S)cc1C
b. CCOc1ccc(NC(=O)CC2C(=O)N(C)C(=S)N2Cc2ccco2)cc1
c. CCCc1cc(=O)[nH]c(SCC(=O)Nc2cc(S(=O)(=O)N3CCCCC3)ccc2C)n1
Answer: a. Cc1ccc(N2C(=O)CN(Cc3ccccc3)C2=S)cc1C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(N2C(=O)CN(Cc3ccccc3)C2=S)cc1C
Cc1ccc(N2C(=O)CN(Cc3ccccc3)C2=S)cc1C
1-benzyl-3-(3,4-dimethylphenyl)-2-sulfanylideneimidazolidin-4-one